A Biomarker Study of ATH434 in Participants With MSA
Study sponsor: Alterity Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-02-26Actual
Enrollment · participants10Actual
Source updated2025-04-01Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.